Overview of the Global Injectable Drug Delivery Technology Market for Therapeutics:
The report spread across 112 pages is an overview of the Global Injectable Drug Delivery Technology Market for Therapeutics. These report study based on the Injectable Drug Delivery Technology Market. It is a complete overview of the market, covering various aspects prevailing market landscape. It accumulates comprehensive information and research methodologies.
The Global Injectable Drug Delivery Technology Market for Therapeutics is expected to witness a CAGR of 10.67%, during the forecast period. North America is estimated to dominate the global injectable drug delivery market in 2017 due to the rising incidences of chronic diseases and presence of major players in this region.
Get a Sample Copy of this Report @ https://marketprognosis.com/sample-request/17176 .
Some of the most common chronic diseases include, heart disease, stroke, type 2 diabetes, obesity, cancer, and arthritis. According to Centers for Disease Control and Prevention (CDC), in United States seven of the top 10 causes of death in 2014 were chronic diseases. Cancer and heart diseases together accounted for an approximate of 46 percent of all deaths. It has also reported that about half of the adults in United States had one or more chronic conditions and one if four had more than two chronic conditions. Moreover, this numbers are expected to increase in the next 10 years. Since, the adoption rate of injectable drug delivery devices is high among the population suffering from diseases, like diabetes and heart related disorders, the increasing prevalence of chronic diseases is expected to contribute for the growth of injectable drug delivery technology market in the forecast period.
Injuries and infections due to needles are acting as a major restraint for the global injectable drug delivery technology market. According to World Health Organization (WHO), globally there were more than 2 million needlestick injuries per year. Another study estimated these numbers often reach more than 3.5 million annually. The European Biosafety Network estimated that in 2007, there were more than 1 million needlestick injuries annually in Europe alone. WHO has estimated that with these numbers are expected to increase by atleast 20% in the next 5 years. Moreover, there has been an increment in the infections caused by needles over the past few years. Therefore, with the increasing injuries and the infections caused by needles, there is reluctance among the population to use the injections, which is hampering the growth of injectable drug delivery technology market, globally.
Purchase this report online with 112 Pages, Top Key Players Analysis and List of Tables & Figure @ https://marketprognosis.com/buyReport/17176 .
Geographically the injectable drug delivery technology market is been segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America holds the major share of approximately more than 42% in 2017 and is expected to grow in the forecast period due to factors, such as rising incidence of cardiovascular diseases, growing geriatric population, and the strong presence of industry players in that region. Europe has holds the second largest position in the market followed by APAC region.
Major Key Players:
1 Becton Dickinson
2 Baxter International
3 Pfizer
4 Gerresheimer AG
5 Terumo Corporation
6 Eli Lily & Company
7 Schott AG and More…………
Any Query? Ask to our Expert @ https://marketprognosis.com/enquiry/17176 .
This study answers to the below key questions:
1 What will the market size be in 2023 and what will the growth rate be?
2 What are the key market trends?
3 What are the challenges to market growth?
4 Who are the key players in this market?
5 What are the market opportunities and threats faced by the key players?
In the end, this report covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Injectable Drug Delivery Technology Market.
Table of Contents:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Key Inferences
5 Market Overview
6 Drivers, Restraints, Opportunities and Challenges Analysis (Droc)
7 Market Segmentation
8 Competitive Landscape
9 Key Players
10 Future Outlook of the Market
Contact us:
ProgMark Pvt. Ltd.
Thane – 421501
India.
[email protected]
+1 973 241 5193
https://www.marketprognosis.com